News
October 2, 2018
Montréal, October 2, 2018 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the election of François Legault and the Coalition Avenir Québec in Quebec on Monday :
October 1, 2018
Toronto, October 1, 2018 – The following is a statement by Jim Keon, President of the Canadian Generic Pharmaceutical Association (CGPA), on the pharmaceutical intellectual property aspects of the United States-Mexico-Canada Agreement (USMCA):
September 24, 2018
Toronto, September 24, 2018 – A new poll confirms that Canadians do not want their access to generic and biosimilar medicines traded away under a new NAFTA deal.